(Bloomberg)—AbbVie Inc. was ordered to pay $150 million to an Oregon man who accused the drugmaker of hiding the heart-attack risks of its AndroGel testosterone booster, a loss for the company in the first case to be weighed by...
Law360, New York (January 9, 2017, 4:27 PM EST) -- A New Hampshire man who supposedly suffered an adverse reaction after his hernia was patched with a polypropylene mesh product launched a lawsuit Monday in federal court claiming the...
A branch of California’s Environmental Protection Agency said Monday that it would add a key ingredient of Roundup herbicide to a list of cancer causing chemicals. If added to the list, the popular weed killer would be required to...
The multidistrict litigation over alleged price-fixing of generic drugs recently consolidated in Pennsylvania's Eastern District has the potential to emerge as one of the thorniest court fights in the country, and some observers have raised concerns that the numerous...
(Reuters) - Johnson & Johnson on Thursday was ordered by a Missouri jury to pay over $110 million to a Virginia woman who says she developed ovarian cancer after decades of using of its talc-based products for feminine hygiene....
Four companies that failed to convince a New York federal court that Goldman Sachs and others manipulated the price of newly smelted aluminum by hoarding the metal in warehouses recently took their dismissed claims to the Second Circuit, according to court...
The information provided by class-actions.us is not a substitute for professional medical advice, diagnosis or treatment.
The views and opinions expressed on the site do not necessarily represent those of class-actions.us.
